NEW YORK STATE ASSEMBLY MEMORANDUM IN SUPPORT OF LEGISLATION submitted in accordance with Assembly Rule III, Sec 1(f)
BILL NUMBER: A6607A
SPONSOR: Cusick TITLE OF BILL: An act to amend the public health law, in relation to
designating certain additional substances as schedule I hallucinogenic
or stimulant controlled substances
PURPOSE OR GENERAL IDEA OF BILL: This bill furthers the fight against
designer drug proliferation in our communities across the state. It
highlights and combats the problem of drugs being sold under the guise
of "research chemicals" and are often labeled "not for human consump-
tion" to avoid potential federal prosecution. However, these substances
remain dangerous and are sold as legal highs. This bill schedules many
of these substances.
SUMMARY OF SPECIFIC PROVISIONS: This bill amends Public Health Law
Section 3306 to add certain designer drugs currently being marketed as
various "research chemicals" to schedule I. "Research Chemicals" is
clearly a misnomer as none of these substances have any legitimate
purpose and instead are dangerous hallucinogens and stimulants.
Section 1 adds the following substances to subdivision (d) Hallucinogen-
ic Substances:
2-(4-bromoZ3,6,7-tetrahydrofuro(2,34)(1)benzofuran-8-y1)ethanamine
(2C-B-FLY); 2-(4-bromo-2,3,6,7-
tetrahydrofuro(2,3-f)benzofuran-8-y1)-1-methyl-ethyl)amine (3C-B-FLY);
2-(4-bromofuro(2,3- f)benzofuran-B-y1)- 1-methyl-ethy1)amine (Bromo-Dra-
gonFLY); 2-(3-methoxypheny1)-2- (ethylamino)cyclohexanone (methoxeta-
mine); 2-(2,5-Dimethoxy-4- ethylphenyl)ethanamine (2C-E);
2-(2,5-Dimethoxy-4-methylpheny1)ethanamine (2C-D);
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
5-Methoxy-N,N-diallyitryptarnine (5-Me0-DALT);
5-Methoxy-N,N-cliisopropytryptamine (5- MeODIPT);
3-Methoxyeticyclidine(3-MeO-PCE); and 4-MethoxyPhencyclidine
(4-1VIeOPCPi methoxydine)
Section 2 adds five substances to subdivision (f) Stimulants:
6,7-dihydro-Slicyclopenta(f) (1,3)benzodioxo1-6-amine or
5,6-Methylenedioxy-2-aminoindane (MDAI);
5-iodo-2,3-dihydro-1Hinden-2-amine (5-1A1);6-(2-aminopropyl)benzofuran
or 1-benzofuran-6-ylpropan-2-amine (6-APB or Benfamine);
2,3-dihydro-1H-inden-2-amine(2-Al); and 2-(Diphenylmethyl)pyrrolidine(2-
diphenylmethylpyrrolidine, desoxy-D2PM).
This bill was amended in 2014 to renumber the five new paragraphs since
laws were enacted in 2013 which necessitated the renumbering of para-
graphs.
JUSTIFICATION: Many designer drugs are making it into communities
around the country and in New York. Many of the substances are shipped
into the United States from Europe, where they have already been banned.
Through the Internet, drug users have been able to share knowledge of up
and coming drugs and how to market them legally in the United States.
In just the past two years, authorities in this country have had to deal
with designer drugs being marketed as legal replacements for marijuana
or drugs being marketed as "bath salts" in an attempt to skirt the law.
Even as authorities take steps to crack down on these substances, new
drugs are reaching our shores and have started killing young people.
These drugs are being marketed as "research chemicals" as a way to avoid
the attention of law-enforcement. However, they come in colorful and
appealing packages with names like "Charly Sheen" and "Pink Panther."
Scheduling these substances will make the now-legal products illegal, as
they should be. Combined with the timely Executive ban of many synthetic
cannabinoids, this legislation will put New York back ahead of the fight
against harmful drugs.
PRIOR LEGISLATIVE HISTORY: Referred to Health.
FISCAL IMPLICATIONS: None to the State.
EFFECTIVE DATE: This act shall take effect on the 180th day after it
shall have become law.
